At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 33 enrolled
Drug / intervention
TAK-438drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-Label, Single-center, Parallel, Phase 1 Study to Determine the Pharmacokinetics of Single- and Multiple- Oral Doses of TAK-438 10 mg and 20 mg in Healthy Adult Chinese Subjects
In Brief
A Phase 1 clinical trial evaluating TAK-438 for Healthy Participants. Completed, enrolled 33 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the pharmacokinetics (PK) of TAK-438 in healthy adult Chinese participants after both single and multiple dose administration.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Participants
CountriesChina
Collaborators--
Timeline
Phase 1CompletedFinished
2017201820192020202120222023202420252026
First PostedMar 2017
Enrollment StartApr 2017
Primary CompletionAug 2017
TodayJul 2026
First PostedMar 21, 2017
Enrollment StartApr 19, 2017
Primary CompletionAug 17, 2017
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 9.3 years ago
Interventions
TAK-438drug
TAK-438 tablets.